Literature DB >> 10087313

Effects of granisetron in children undergoing high-dose chemotherapy: a multi-institutional, cross-over study.

Y Tsuchida1, Y Hayashi, K Asami, K Yamamoto, J Yokoyama, H Mugishima, T Honna, J Mimaya, F Hara, T Sawada, T Matsumura, S Suita, T Sugimoto, M Kaneko.   

Abstract

The efficacy of granisetron hydrochloride 20 microg/kg and 40 microg/kg were compared using a cross-over method to determine the optimal dose in children with solid tumors receiving high-dose chemotherapy. Granisetron controlled the onset of vomiting in 17 of 23 patients (73.9%) who were given 40 microg/kg of granisetron, while 8 of 21 patients (38.1%) were free of vomiting in the 20 microg/kg group. The average frequency of vomiting was 7.22 times in the 20 microg/kg dose versus 4.44 times in the 40 microg/kg dose. No safety problems were associated with either dose. The 40 microg/kg dose of granisetron appears to be more optimal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087313     DOI: 10.3892/ijo.14.4.673

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

Review 1.  Stratified administration of serotonin 5-HT3 receptor antagonists (setrons) for chemotherapy-induced emesis. Economic implications.

Authors:  L A Sanchez; M Holdsworth; S B Bartel
Journal:  Pharmacoeconomics       Date:  2000-12       Impact factor: 4.981

2.  Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial.

Authors:  F B Cakir; O Yapar; C Canpolat; F Akalin; S G Berrak
Journal:  Support Care Cancer       Date:  2012-01-13       Impact factor: 3.603

3.  A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.

Authors:  Su G Berrak; Nihal Ozdemir; Nadi Bakirci; Emine Turkkan; Cengiz Canpolat; Bahar Beker; Asim Yoruk
Journal:  Support Care Cancer       Date:  2007-03-20       Impact factor: 3.603

Review 4.  Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.

Authors:  L Lee Dupuis; Paul C Nathan
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Authors:  Robert S Phillips; Amanda J Friend; Faith Gibson; Elizabeth Houghton; Shireen Gopaul; Jean V Craig; Barry Pizer
Journal:  Cochrane Database Syst Rev       Date:  2016-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.